. 2021 Dec 7;38(4):273–285. doi: 10.4274/tjh.galenos.2021.2021.0007
© Copyright 2021 by Turkish Society of Hematology / Turkish Journal of Hematology, Published by Galenos Publishing House.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Table 3. Characteristics of ibrutinib therapy.
